Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Florence T. Wang"'
Autor:
Andrea K. Chomistek, Caihua Liang, Michael C. Doherty, C. Robin Clifford, Rachel P. Ogilvie, Robert V. Gately, Jennifer N. Song, Cheryl Enger, Nancy D. Lin, Florence T. Wang, John D. Seeger
Publikováno v:
BMC Infectious Diseases, Vol 22, Iss 1, Pp 1-13 (2022)
Abstract Background There are limited data on risk factors for serious outcomes and death from COVID-19 among patients representative of the U.S. population. The objective of this study was to determine risk factors for critical care, ventilation, an
Externí odkaz:
https://doaj.org/article/351b4730558741a3979d9fb4610c4d89
Publikováno v:
BMC Health Services Research, Vol 18, Iss 1, Pp 1-6 (2018)
Abstract Background Post-marketing safety studies of medicines often rely on administrative claims databases to identify adverse outcomes following drug exposure. Valid ascertainment of outcomes is essential for accurate results. We aim to quantify t
Externí odkaz:
https://doaj.org/article/211f7c945ed043f794998b514e67f2ec
Autor:
Andrea K. Chomistek, Veena Hoffman, Robert Urman, Karminder S. Gill, Stephen M. Ezzy, Li Zhou, Andrew S. Park, Brett Loop, Sandra Lopez-Leon, Peter McAllister, Florence T. Wang
Publikováno v:
Pain and Therapy. 11:1415-1437
Erenumab, an anti-calcitonin gene-related peptide (CGRP) receptor monoclonal antibody (mAb), was approved by the US Food and Drug Administration in May 2018. Constipation with serious complications was added to the Warning and Precautions section in
Autor:
Sigal Kaplan, Monica L. Bertoia, Amir Lass, Florence T. Wang, Alison Evans, Sandeep Dhanda, Debabrata Roy, John D. Seeger
Publikováno v:
Pharmacoepidemiology and Drug Safety. 32:78-83
As part of the European risk management plan of a 91-day extended levonorgestrel-containing combined oral contraceptive (COCWe conducted a retrospective cohort study in new users of 91-day COCThe 91-day and 28-day COCSmall differences were observed f
Autor:
Andrea K Chomistek, Jessica M Franklin, Rachel Sobel, Andrea Marcus, Sarah-Jo Sinnott, Ashley Howell, Ihtisham Sultan, Jonathan I Silverberg, Florence T Wang
Publikováno v:
British Journal of Dermatology. 188
Real-world data (RWD) source such as insurance claims data, provides the opportunity to draw on the experience of thousands of patients treated in routine clinical practice to better understand the relationships between exposures and outcomes. Noneth
Autor:
Monica L. Bertoia, Kelesitse Phiri, C. Robin Clifford, Michael Doherty, Li Zhou, Laura T. Wang, Natalie A. Bertoia, Florence T. Wang, John D. Seeger
Publikováno v:
Pharmacoepidemiology and drug safety. 31(8)
Health care insurance claims databases are becoming a more common data source for studies of medication safety during pregnancy. While pregnancies have historically been identified in such databases by pregnancy outcomes, International Classification
Publikováno v:
Clinical Epidemiology
Lauren AS Stevens,1 Leslie Spangler,2 Laura Yochum,1 Yan Ding,1 Florence T Wang1 1Optum Epidemiology, Optum, Boston, MA, USA; 2Center for Observational Research, Amgen, Inc., Thousand Oaks, CA, USACorrespondence: Florence T WangOptum Epidemiology, Op
Autor:
Sigal Kaplan, Alison Evans, John D. Seeger, Debabrata Roy, Li Zhou, Florence T. Wang, Amir Lass, Monica L. Bertoia, Sandeep Dhanda
Publikováno v:
Contraception. 105
Objectives To compare the safety profile of Seasonique, a 91-day levonorgestrel-containing combined oral contraceptive (COCLNG), to 28-day COCLNG regarding the risk of venous thromboembolism (VTE) and arterial thromboembolism (ATE). Study Design A ne
Autor:
Caihua Liang, Rachel P. Ogilvie, Michael Doherty, C. Robin Clifford, Andrea K. Chomistek, Robert Gately, Jennifer Song, Cheryl Enger, John Seeger, Nancy D. Lin, Florence T. Wang
Publikováno v:
PLOS ONE. 17:e0271501
Background Electronic health record (EHR) databases provide an opportunity to facilitate characterization and trends in patients with COVID-19. Methods Patients with COVID-19 were identified based on an ICD-10 diagnosis code for COVID-19 (U07.1) and/
Autor:
Andrea K. Chomistek, Caihua Liang, Michael C. Doherty, C. Robin Clifford, Rachel P. Ogilvie, Robert V. Gately, Jennifer N. Song, Cheryl Enger, Nancy D. Lin, Florence T. Wang, John D. Seeger
Publikováno v:
BMC infectious diseases. 22(1)
Background There are limited data on risk factors for serious outcomes and death from COVID-19 among patients representative of the U.S. population. The objective of this study was to determine risk factors for critical care, ventilation, and death a